NCT07922772
Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
StatusNot Yet Recruiting
PhaseNot applicable
SponsorUniversity of Michigan
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Total number of composite clinical events during follow up
Timeframe: Day 1 (start of randomized treatment) through Month 24 of follow-up
Secondary (9)
Standardized Outcomes in Nephrology - Life Participation (SONG-LP) score (Patient reported outcome)
Illness Intrusiveness Ratings Scale (IIRS) score (Patient reported outcome)
Kidney Disease Quality of Life 36-Item Short Form Summary Score (KDQOL-36 KSS) (Patient reported outcome)
Change in Kidney Disease Quality of Life 36-Item Short Form Survey (KDQOL-36) kidney disease-specific subscale scores (Patient reported outcome)
Number of episodes of low small-solute clearance (weekly Kt/V [peritoneal + renal] < 1.7).
Show 4 moreShow less
Number of episodes of serum potassium ≥ 6.0 mEq/L
Number of episodes of serum phosphate ≥ 7.0 mg/dL
Number of episodes of serum CO2 ≤17 mmol/L
Number of episodes of serum sodium < 130 mEq/L
Arms and interventions
Daily Peritoneal Dialysis (7 days/week)Active comparator
Approximately 225 participants
Days-off Peritoneal Dialysis (5-6 days/week)Experimental
Approximately 225 participants
Procedures: Daily Peritoneal Dialysis, Days-off Peritoneal Dialysis
Sites
10 sites in 1 country